Yibin Zhao

Dr. Yibin Zhao


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 April 2026 in Translational Cancer Research
Verified
Journal Article
Open access
PDF file
HZHongyi Zhou
Hongyi Zhou
XQXiaohong Qian
Xiaohong Qian
QDQiujun Dai
Qiujun Dai
QZQiqi Zhu
Qiqi Zhu
PLPeiyuan Li
Peiyuan Li
YZYibin Zhao
Yibin Zhao
Background: Colorectal cancer (CRC) exhibits significant heterogeneity between left-sided (LCC) and right-sided (RCC) subtypes, influenced by tertiary lymphoid structures-related genes (TLSRGs). This study aimed to explore TLSRGs’ roles in LCC/RCC differences, including expression, mutations, prognosis, and molecular pathways, while developing a prognostic risk model. Methods: Data were integrated from The Cancer Genome Atlas Colon Adenocarcinoma (TCGA-COAD) (324 samples: 135 LCC, 189 RCC) and Gene Expression Omnibus (GEO) datasets. TLSRGs were analyzed for differential expression, mutations, and prognostic associations using Wilcoxon tests, Cox regression, and gene set variation analysis (GSVA). Consensus clustering identified molecular subtypes. Single-cell analysis involved Seurat/Harmony for clustering and annotation, single-sample gene set enrichment analysis (ssGSEA) for scoring, and CellChat for cell communication. A machine learning-based risk model was constructed by screening ten algorithms (including SuperPC, RSF, CoxBoost, etc.) using the Mime package. The SuperPC algorithm demonstrated the best performance and was built on TLSRGs and related pathways, validated via Concordance index (C-index), Kaplan-Meier (KM) curves, and receiver operating characteristic (ROC) analysis. Results: Integrated analysis revealed significant heterogeneity between LCC and RCC, characterized by distinct somatic mutation profiles, differential expression of 27 TLSRGs, and subtype stratification via TLSRG-based consensus clustering (C1 enriched in RCC, P<0.001, with higher GSVA activity, P<0.001). Single-cell transcriptomics demonstrated reduced T-cell proportions, elevated epithelial cells, and lower tertiary lymphoid structure (TLS) scores in RCC, alongside weakened cell-cell communication strength (notably epithelial-T/B cell interactions). Prognostic genes exhibited location-specificity: FBLN7 [hazard ratio (HR) =7.09 for disease-specific survival (DSS)] and MS4A1 [HR =7.79 for disease-free interval (DFI)] predicted poor survival in LCC, while ICOS was protective in RCC [HR =0.42 for overall survival (OS)]. Drug sensitivity screening identified 22 agents with differential half-maximal inhibitory concentration (IC50) correlated to TLSRG expression, and immune infiltration analysis revealed reduced CD8+ T cells/follicular helper T cells in RCC. An 8-gene prognostic signature (HSPB1, NCOR2, STIL, etc.) derived via SuperPC effectively stratified high-risk patients in TCGA (HR =2.06, P=0.001) and GSE103479 (HR =1.86, P=0.02), with consistent performance across LCC/RCC subgroups. Conclusions: TLSRGs underpin LCC/RCC heterogeneity in mutations, expression, immunity, and cell interactions. The developed risk model offers robust prognostic value, highlighting potential therapeutic targets for sidedness-specific CRC management.

9 September 2025 in International Journal of Surgery
Verified
Journal Article
Open access
YZYibin Zhao
Yibin Zhao
HLHao Liu
Hao Liu
YWYu Wang
Yu Wang
JSJie Shen
Jie Shen
YLYang Le
Yang Le
WCWei Cui
Wei Cui
Background: Right-sided colon cancer (RCC) and left-sided colon cancer (LCC) exhibit distinct clinical behaviors and molecular characteristics, but immune microenvironmental differences remain unclear. Methods: Single-cell RNA sequencing was performed on three LCC and three RCC tumors. Validation studies included immunofluorescence on 70 patients (30 LCC and 40 RCC). Analytical methods comprised cellular heterogeneity assessment (Seurat, inferCNV), pseudotime trajectory reconstruction (Monocle2), pathway enrichment (GSVA), and cell-cell communication inference (CellChat). Results: RCC displayed significantly increased exhausted CD8 + T cells and decreased activated CD8 + T cells compared to the LCC. Concurrently, RCC showed reduced proportions of TNF + mast cells (MCs) and increased VEGFA + MCs. We identified a CASC15 + KLK6 + epithelial subpopulation specifically enriched in RCC tumors, exhibiting high copy number variation scores, elevated malignant pathway activity, and a significant negative correlation with patient survival (r = − 0.2919, p = 0.0142). Enhanced intercellular communication involving MIF signaling (CD74/CXCR4/CD44) and CD99 pathways was observed between epithelial cells, T cells, and MCs in RCC. Conclusion: RCC harbors an immunosuppressive niche driven by T-cell exhaustion, MC reprogramming, and expansion of a malignant CASC15 + KLK6 + epithelial subpopulation. Targeting MIF and CD99 signaling networks represents a potential therapeutic strategy for RCC.